Natural Variation in HIV-1 Protease, Gag p7 and p6, and Protease Cleavage Sites within Gag/Pol Polyproteins: Amino Acid Substitutions in the Absence of Protease Inhibitors in Mothers and Children Infected by Human Immunodeficiency Virus Type 1

Virology

Volumn 219, Issue 2, 1996, Pages 407-416

  Barrie, Kimberly A ^a,b   Perez, Elena E ^a   Lamers, Susanna L ^a,c   Farmerie, William G ^a   Dunn, Ben M ^a   Sleasman, John W ^a   Goodenow, Maureen M ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Gene Genie Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

PROTEIN; PROTEINASE; PROTEINASE INHIBITOR;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; VERTICAL TRANSMISSION;

ALLELES; AMINO ACID SEQUENCE; ANTIVIRAL AGENTS; BASE SEQUENCE; BINDING SITES; CAPSID; CAPSID PROTEINS; CHILD; CROSS-SECTIONAL STUDIES; DNA PRIMERS; GENE PRODUCTS, GAG; GENE PRODUCTS, POL; HIV INFECTIONS; HIV PROTEASE; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; PROTEIN PRECURSORS; VARIATION (GENETICS); VIRAL PROTEINS;

EID: 0030007802     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0266     Document Type: Article

References (47)

1. Aleixo, L. F., Goodenow, M. M., and Sleasman, J. W. (1995). Molecular analysis of highly enriched populations of T cell depleted monocytes. Clin. Diagn. Lab. Immunol. 2, 733-739.
2. Baldwin, E. T., Bhat, T. N., Liu, B., Pattabiraman, N., and Erickson, J. W. (1995). Structural basis of drug resistance for the V82A mutant of HIV-1 proteinase. Nat. Struct. Biol. 2, 244-249.
3. Centers for Disease Control and Prevention. (1994). Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 43, 1-10.
4. Coffin, J. M. (1995). HIV population dynamics in vivo: Implications for genetic variation, pathogenesis, and therapy. Science 267, 483-489.
5. Collins, J. R., Burt, S. K., and Erickson, J. W. (1995). Flap opening in HIV-1 protease simulated by 'activated' dynamics. Nat. Struct. Biol. 2, 334-338.
6. Condra, J., Schleif, W., Blahy, O., Gabryelski, L., Graham, D., Quintero, J., Rhodes, A., Robbins, H., Roth, E., Shivaprakash, M., Titus, D., Yang, T., Teppler, H., Squires, K., Duetsch, P., and Emini, E. (1995). In vivo emergency of HIV-1 variants resistant to multiple protease inhibitors. Nature 374, 569-571.
7. Debouck, C. (1992). HIV-1 protease as a therapeutic target for AIDS. AIDS Res. Hum. Retroviruses 8, 153-164.
8. Dorfman, T., Luban, J., Goff, S. P., Haseltine, W. A., and Gottlinger, H. G. (1993). Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein. J. Virol. 67, 6159-6169.
9. El-Farrash, M. A., Kuroda, M. J., Kitazaki, T., Masuda, T., Kato, K., Hatanka, M., and Harada, S. (1994). Generation and characterization of a human immunodeficiency virus type 1 (HIV-1) mutant resistant to an HIV-1 protease inhibitor. J. Virol. 68, 233-239.
10. Felsenstein, J. (1993). PHYLIP (phylogeny interference package), Version 3.5c. Department of Genetics, University of Washington, Seattle.
11. Folks, T. M., Powell, D., Lightfoote, M., Koenig, S., Fauci, A. S., Benn, S., Rabson, A., Daugherty, D., Gendelman, H. E., Venkatesan, S., and Martin, M. A. (1986). Biological and biochemical characterization of a cloned Leu-3-cell surviving infection with the acquired immune deficiency syndrome retrovirus. J. Exp. Med. 164, 280-290.
12. Fontenot, G., Johnston, K., Cohen, J. C., Gallaher, W. R., Robinson, J., and Luftig, R. B. (1992). PCR amplification of HIV-1 proteinase sequences directly from lab isolates allows determination of five conserved domains. Virology 190, 1-10.
13. Goodenow, M. M., Huet, T., Saurin, W., Kowk, S., Sninsky, J., and Wain Hobson, S. (1989) HIV-1 isolates are rapidly evolving quasispecies: Evidence for viral mixtures and preferred nucleotide substitutions. J. Acquired Immune Defic. Syndr. 2, 344-352.
14. Gorelick, R. J., Chabot, D. J., Rein, A., Henderson, L. E., and Arthur, L. O. (1993). The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent. J. Virol. 67, 4027-4036.
15. Gottlinger, H., Dorfman, T., Sodroski, J., and Haseltine, W. (1991). Effect of mutations affecting the p6 gag protein on human immunodeficiency viral particle release. Proc. Natl. Acad. Sci. USA 88, 3195-3199.
16. Graves, M. (1991). HIV proteinase: Now, then, what's next? In "Structure and Function of the Aspartic Proteinases" (B. M. Dunn, Ed.). Plenum, New York.
17. Gulnik, S. V., Suvorov, L. I., Liu, B., Yu., B., Anderson, B., Mitsuya, H., and Erickson, J. W. (1995). Kinetic characterization and cross-resistance patterns of HIV-1 protease mutants selected under drug pressure. Biochemistry 34, 9282-9287.
18. 2-symmetric protease inhibitor. J. Virol. 68, 2016-2020.
19. Janvier, B., Baillous, A., Archinard, P., Mounier, M., Mandrand, B., Goudeau, A., and Barin, F. (1991). Immune response to a major epitope of p24 during infection with human immunodeficiency virus type 1 and implications for diagnosis and prognosis. J. Clin. Microbiol. 29, 88-92.
20. Kaplan, A. H., Zack, J. A., Knigge, M., Paul, D. A., Kempf, D. J., Norbeck, D. W., and Swanstrom, R. (1993). Partial inhibition of the human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particles. J. Virol. 67, 4050-4055.
21. Kaplan, A. H., Michael, S. F., Wehbie, R. S., Knigge, M. F., Paul, D. A., Everitt, L., Kempf, D. J., Norbeck, D. W., Erickson, J. W., and Swanstrom, R. (1994). Selection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of viral protease. Proc. Natl. Acad. Sci. USA 91, 5597-5601.
22. Katz, R. A., and Skalka, A. M. (1994). The retroviral enzymes. Annu. Rev. Biochem. 63, 133-173.
23. Kinney, J. S., Conway, J. H., Hilgartner M. W., et al. (1991). Humoral immune responses to Gag and Env proteins from human immunodeficiency virus type 1 in hemophiliac patients. Am. J. Hematol. 36, 35-41.
24. Kohl, H., Emini, E., Schleif, W., Davis, L. J., Heimbach, J. C., Dixon, R. A. Scolnick, E. M., and Sigal, I. S. (1988). Active human immunodeficiency virus protease is required for viral infectivity. Proc. Natl. Acad. Sci. USA 85, 4686-4690.
25. Lamers, S. L., Seasman, J. W., She, J. X., Barrie, K. A., Pomeroy, S. M., Barrett, D. J., and Goodenow, M. M. (1994). Persistence of multiple maternal genotypes of HIV-1 in infants infected by vertical transmission. J. Clin. Invest. 93, 380-390.
26. Lin, Y., Lin, X., Long, L., Foundling, S., Heinrikson, R. L., Thaisrivongs, S., Leelamanit, W., Raterman, D., Shah, M., and Dunn, B. M. (1995). Effect of point mutations on the kinetics and the inhibition of human immunodeficiency virus type 1 protease: Relationship to drug resistance. Biochemistry 34, 1143-1152.
27. Loeb, D., Swanstrom, R., Everitt, L., Manchester, M., Stamper, S., and Hutchinson, C., III. (1989). Complete mutagenesis of the HIV-1 protease. Nature 340, 397-400.
28. Louwagie, J., McCutchan, F., Peeters, M., Brennan, T., Sanders Buell, E., Eddy, G., van der Groen, G., Fransen, K., Gershy-Damet, G. N. M., Deleys, R., and Burke, D. (1993). Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS Res. Hum. Retroviruses 7, 769-780.
29. Markowitz, M., Mo, H., Kempf, D. J., Norbeck, D. W., Bhat, T. N., Erickson, J. W., and Ho, D. D. (1995). Selection and analysis of human immunodeficiency virus type 1 variants with increased resistance to ABT-538, a novel protease inhibitor. J. Virol. 69, 701-706.
30. Mellors, J., Larder, B., and Schinazi, R. (1994). Mutations in HIV-1 reverse transcriptase and protease associated with drug resistance. In "Human Retroviruses and AIDS 1994: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences" (G. Myers, S. Korber, S. Wain-Hobson, R. F. Smith, and G. N. Pavlakis, Eds.), pp. III 93-III 106. Los Alamos National Laboratory, Theoretical Biology and Biophysics, Los Alamos, NM.
31. Moody, M. D., Pettit, S. C., Shao, W., Everitt, L., Loeb, D. D., Hutchison, C. A., and Swanstrom, R. (1995). A side chain at position 40 of the human immunodeficiency virus type-1 protease flap provides an additional specificity determinant. Virology 207, 475-485.
32. Myers, G., Korber, S., Wain-Hobson, S., Smith, R. F., and Pavlakis, G. N. (1994). "Human Retroviruses and AIDS 1994: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences." Los Alamos National Laboratory, Theoretical Biology and Biophysics, Los Alamos, NM.
33. Nagy, K., Young, M., Baboonian, C., Merson, J., Whittle, P., and Oroszlan, S. (1994). Antiviral activity of human immunodeficiency virus type 1 protease inhibitors in a single cycle of infection: Evidence for a role of protease in the early phase. J. Virol. 68, 757-765.
34. Nei, M., and Jin, L. (1989). Variances of the average numbers of nucleotide substitutions within and between populations. Mol. Biol. Evol. 6, 290-300.
35. Otto, M. J., Garber, S., Winslow, D. L., Reid, C. D., Aldrich, P., Jadhav, P. K., Patterson, C. E., Hodge, C. N., and Cheng, Y. S. (1993). In vitro isolation and identification of human immunodeficiency virus (HIV) variants with reduced sensitivity to C-2 symmetrical inhibitors of HIV type-1 protease. Proc. Natl. Acad. Sci. USA 90, 7543-7547.
36. Partaledis, J. A., Yamaguchi, K., Tisdale, M., Blair, E. E., Falcione, C., Maschera, B., Myers, R. E., Pazhanisamy, S., Futer, O., and Cullinan, A. B. (1995). In vitro selection and characterization of human immunodeficieny virus type 1 (HIV-1) isolates with reduced sensitivity to hydroxyethylamino sulfonamide inhibitors of HIV-1 aspartyl protease. J. Virol. 69, 5228-5235.
37. Partin, K., Zybarth, G., Ehrlich, L., Decrombrugghe, M., Wimmer, E., and Carter, C. (1991). Deletion of sequences upstream of the proteinase improves the proteolytic processing of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 88, 4776-4780.
38. Patick, A. F., Rose, R., Greytok, J., Bechtold, C. M., Hermsmeier, M. A., Chen, P. T., Barish, J. C., Zahler, R., Colonno, R. J., and Lin, P. F. (1995). Characterization of a human immunodeficiency virus type 1 variant with reduced sensitivity to an aminodiol protease inhibitor. J. Virol. 69, 2148-2152.
39. ELI. Virology 181, 661-672.
40. Pettit, S. C., Moody, M. D., Wehbie, R. S., Kaplan, A. H., Nantermet, P. V., Klein, C. A., and Swanstrom, R. (1994). The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions. J. Virol. 68, 8017-8027.
41. Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., and Erlich, H. A. (1988). Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239, 487-491.
42. Swanstrom, R. (1994). Characterization of HIV-1 protease mutants: Random, directed, selected. Curr. Opin. Biotechnol. 5, 409-413.
43. Tritch, R., Cheng, Y., Yin, F., and Erickson-Viitanen, S. (1991). Mutagenesis of protease cleavage sites in the human immunodeficiency virus type 1 gag polyprotein. J. Virol. 65, 922-930.
44. Wei, X., Ohosh, S., Taylor, M., Johnson, V., Emuni, E., Deutsch, P., Lifson, J., Bonhoeffer, S., Nowak, M., Hahn, B., Saag, M., and Shaw, G. (1995). Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373, 117-122.
45. Winslow, D., Stack, S., King, R., Scarnati, H., Binesik, A., and Otto, M. (1995). Limited sequence diversity of the HIV-1 protease gene from clinical isolates and in vitro susceptibility to HIV protease inhibitors. AIDS Res. Hum. Retroviruses 11, 107-113.
46. Wlodawer, A., and Erickson, J. W. (1993). Structure-based inhibitors of HIV-1 protease. Annu. Rev. Biochem. 62, 543-585.
47. Zybarth, G., and Carter, C. (1995). Domains upstream of the protease in human immunodeficiency virus type 1 Gag-Pol influence PR autoprocessing. J. Virol. 69, 3878-3884.